Association of high-sensitivity C-reactive protein with de novo major depression

Pasco, Julie A., Nicholson, Geoffrey C., Williams, Lana J., Jacka, Felice N., Henry, Margaret J., Kotowicz, Mark A., Schneider, Hans G., Leonard, Brian E. and Berk, Michael (2010) Association of high-sensitivity C-reactive protein with de novo major depression. British Journal of Psychiatry, 197 5: 372-377. doi:10.1192/bjp.bp.109.076430


Author Pasco, Julie A.
Nicholson, Geoffrey C.
Williams, Lana J.
Jacka, Felice N.
Henry, Margaret J.
Kotowicz, Mark A.
Schneider, Hans G.
Leonard, Brian E.
Berk, Michael
Title Association of high-sensitivity C-reactive protein with de novo major depression
Formatted title
Association of high-sensitivity C-reactive protein with de novo major depression
Journal name British Journal of Psychiatry   Check publisher's open access policy
ISSN 0007-1250
1472-1465
Publication date 2010-11
Sub-type Article (original research)
DOI 10.1192/bjp.bp.109.076430
Volume 197
Issue 5
Start page 372
End page 377
Total pages 6
Place of publication London, United Kingdom
Publisher Royal College of Psychiatrists
Language eng
Formatted abstract
Background Although there is cross-sectional evidence that changes in the immune system contribute to the pathophysiology of depression, longitudinal data capable of elucidating cause and effect relationships are lacking.
Aims We aimed to determine whether subclinical systemic inflammation, as measured by serum high-sensitivity C-reactive protein (hsCRP) concentration, is associated with an increased risk of de novo major depressive disorder.
Method Major depressive disorder was diagnosed using a clinical interview (SCID–I/NP). This is a retrospective cohort study; from a population-based sample of 1494 randomly selected women recruited at baseline during the period 1994–7, 822 were followed for a decade and provided measures of both exposure and outcome. Of these women, 644 (aged 20–84 years) had no prior history of depression at baseline and were eligible for analysis.
Results During 5827 person-years of follow-up, 48 cases of de novo major depressive disorder were identified. The hazard ratio (HR) for depression increased by 44% for each standard deviation increase in log-transformed hsCRP (ln-hsCRP) (HR = 1.44, 95% CI 1.04–1.99), after adjusting for weight, smoking and use of non-steroidal anti-inflammatory drugs. Further adjustment for other lifestyle factors, medications and comorbidity failed to explain the observed increased risk for depression.
Conclusions Serum hsCRP is an independent risk marker for de novo major depressive disorder in women. This supports an aetiological role for inflammatory activity in the pathophysiology of depression.
Q-Index Code C1
Q-Index Status Provisional Code
Institutional Status Non-UQ

Document type: Journal Article
Sub-type: Article (original research)
Collections: ERA 2012 Admin Only
School of Medicine Publications
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 101 times in Thomson Reuters Web of Science Article | Citations
Scopus Citation Count Cited 106 times in Scopus Article | Citations
Google Scholar Search Google Scholar
Created: Sun, 11 Sep 2011, 20:46:33 EST by System User on behalf of Rural Clinical School